UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Pflügers Archiv, ISSN 0031-6768, 3/2011, Volume 461, Issue 3, pp. 325 - 335
Regeneration | Myosin heavy chain | Myogenic response | Biomedicine | Human Physiology | Muscle damage | Skeletal muscle | Life Sciences & Biomedicine | Physiology | Science & Technology | Muscular Atrophy - metabolism | Fasting - physiology | Humans | SKP Cullin F-Box Protein Ligases - physiology | Immobilization - adverse effects | Pulmonary Disease, Chronic Obstructive - physiopathology | Sepsis - physiopathology | Ubiquitin-Protein Ligases - physiology | Tripartite Motif Proteins | Acquired Immunodeficiency Syndrome - physiopathology | Animals | Renal Insufficiency - physiopathology | Aging - physiology | Diabetes Mellitus - physiopathology | Spinal Cord Injuries - physiopathology | Muscle Proteins - physiology | Cachexia - physiopathology | Denervation | Ubiquitin | Chronic diseases | Messenger RNA | Muscle proteins | Ligases | Myosin | Index Medicus
Journal Article
Medicine and science in sports and exercise, ISSN 0195-9131, 11/2016, Volume 48, Issue 11, pp. 2307 - 2319
OXIDATIVE STRESS | CRITICAL ILLNESS | MUSCLE ATROPHY | MECHANICAL VENTILATION | NEUROLOGICAL DISORDERS | NECROSIS-FACTOR-ALPHA | INDUCED DIAPHRAGM DYSFUNCTION | CANCER | CANCER-RELATED FATIGUE | TUMOR-BEARING MICE | MULTIPLE-SCLEROSIS | INTENSIVE-CARE-UNIT | DIRECTED MYOSTATIN INHIBITION | RENIN-ANGIOTENSIN SYSTEM | INFLAMMATION | Muscular Atrophy - physiopathology | Humans | Critical Illness | Nervous System Diseases - physiopathology | Neoplasms - physiopathology | Muscle Fatigue - physiology | Chronic Disease | Cachexia - physiopathology | Inflammation - physiopathology | Muscles | Fatigue | Research | Index Medicus | cancer | muscle atrophy | inflammation | critical illness | neurological disorders
Journal Article
Journal of child neurology, ISSN 0883-0738, 08/2007, Volume 22, Issue 8, pp. 1027 - 1049
Standard of care | Consensus statement | Spinal muscular atrophy | Muscular Atrophy, Spinal - diagnosis | Postoperative Complications - etiology | Gastrointestinal Diseases - physiopathology | Humans | Gastrointestinal Diseases - etiology | Postoperative Complications - prevention & control | Respiratory Insufficiency - etiology | Respiratory Paralysis - therapy | Respiratory Paralysis - physiopathology | Deglutition Disorders - therapy | Child Nutrition Disorders - etiology | Respiratory Paralysis - etiology | Child Nutrition Disorders - physiopathology | Gait Disorders, Neurologic - physiopathology | Child Nutrition Disorders - prevention & control | Deglutition Disorders - etiology | Child | Deglutition Disorders - physiopathology | Respiratory Insufficiency - physiopathology | Diagnosis, Differential | Gastrointestinal Diseases - therapy | Respiratory Insufficiency - therapy | Consensus | Gait Disorders, Neurologic - therapy | Muscular Atrophy, Spinal - therapy | Muscular Atrophy, Spinal - complications | Gait Disorders, Neurologic - etiology | Index Medicus
Journal Article
Physiology, ISSN 1548-9213, 06/2008, Volume 23, Issue 3, pp. 160 - 170
Life Sciences & Biomedicine | Physiology | Science & Technology | Animals | Muscular Atrophy - physiopathology | Humans | Muscle Contraction - physiology | Muscle, Skeletal - physiopathology | Muscle, Skeletal - metabolism | Signal Transduction - physiology | Muscle, Skeletal - pathology | Contractile Proteins - metabolism | Hypertrophy - physiopathology | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 2811 - 16
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fibronectins - administration & dosage | Humans | Femur - drug effects | Muscular Atrophy - genetics | Recombinant Proteins - genetics | Femur - physiopathology | Muscular Atrophy - drug therapy | Hindlimb Suspension - physiology | Recombinant Proteins - administration & dosage | Bone Diseases, Metabolic - drug therapy | Bone Density - drug effects | Animals | Muscular Atrophy - physiopathology | Muscle, Skeletal - drug effects | Muscle, Skeletal - physiopathology | Lower Extremity - physiopathology | Fibronectins - genetics | Mice | Bone Diseases, Metabolic - genetics | Bone Diseases, Metabolic - physiopathology | Physical Conditioning, Animal | Atrophy | Osteoporosis | Bone mass | Computed tomography | Myosin | Bone mineral density | Bone loss | Bone (cortical) | Bone (trabecular) | Microgravity | Skeletal muscle | Geriatrics | Index Medicus
Journal Article
European journal of neurology, ISSN 1351-5101, 03/2018, Volume 25, Issue 3, pp. 512 - 518
muscle strength | NUSINERSEN | SMA | DISEASE | spinal muscular atrophy | milestones | NATURAL-HISTORY | natural history | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cross-Sectional Studies | Motor Skills - physiology | Humans | Middle Aged | Child, Preschool | Infant | Male | Disease Progression | Young Adult | Muscle, Skeletal - physiopathology | Adolescent | Adult | Female | Aged | Spinal Muscular Atrophies of Childhood - physiopathology | Muscle Weakness - physiopathology | Child | Muscular Atrophy, Spinal - physiopathology | Muscle Strength - physiology | Medical research | Analysis | Medicine, Experimental | Explosives | Children | Spinal muscular atrophy | Diseases | Cluster analysis | Cell survival | Human motion | Motor ability | Muscles | Motor skill | Infants | Patients | Atrophy | Skills | Quadriceps muscle | Muscular strength | Age | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 18, pp. 1723 - 1732
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Injections, Spinal | Spinal Muscular Atrophies of Childhood - genetics | Double-Blind Method | Oligonucleotides - therapeutic use | Humans | Spinal Muscular Atrophies of Childhood - drug therapy | Infant | Male | Oligonucleotides - adverse effects | Oligonucleotides, Antisense - adverse effects | RNA, Messenger - metabolism | Survival of Motor Neuron 2 Protein - metabolism | Respiration, Artificial | Disease-Free Survival | Oligonucleotides, Antisense - therapeutic use | Survival of Motor Neuron 2 Protein - genetics | Age of Onset | Survival Analysis | Female | Spinal Muscular Atrophies of Childhood - mortality | Spinal Muscular Atrophies of Childhood - physiopathology | Motor Skills | RNA, Messenger - drug effects | Care and treatment | Usage | Surgery | Patient outcomes | Motor ability | Analysis | Spinal muscular atrophy | Pediatrics | Neuromuscular diseases | Cell survival | Splicing | Neurons | SMN protein | Antisense oligonucleotides | mRNA | Infants | Motor task performance | Hereditary diseases | Children & youth | Babies | Proteins | Neurology | Ventilation | Death | Mutation | Drug therapy | Drug dosages | Age | Index Medicus | Abridged Index Medicus | trials | Pediatrik
Journal Article